CH460025A - Procédé de préparation de nouvelles cytosines - Google Patents

Procédé de préparation de nouvelles cytosines

Info

Publication number
CH460025A
CH460025A CH693068A CH693068A CH460025A CH 460025 A CH460025 A CH 460025A CH 693068 A CH693068 A CH 693068A CH 693068 A CH693068 A CH 693068A CH 460025 A CH460025 A CH 460025A
Authority
CH
Switzerland
Prior art keywords
cytosines
preparation
new
new cytosines
Prior art date
Application number
CH693068A
Other languages
English (en)
Inventor
Doub Leonard
Krolls Uldis
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of CH460025A publication Critical patent/CH460025A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CH693068A 1965-08-02 1966-08-01 Procédé de préparation de nouvelles cytosines CH460025A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US476694A US3375247A (en) 1965-08-02 1965-08-02 Heterocyclic compounds and methods for their production

Publications (1)

Publication Number Publication Date
CH460025A true CH460025A (fr) 1968-07-31

Family

ID=23892882

Family Applications (2)

Application Number Title Priority Date Filing Date
CH693068A CH460025A (fr) 1965-08-02 1966-08-01 Procédé de préparation de nouvelles cytosines
CH1109666A CH460024A (fr) 1965-08-02 1966-08-01 Procédé de préparation de nouvelles cytosines

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH1109666A CH460024A (fr) 1965-08-02 1966-08-01 Procédé de préparation de nouvelles cytosines

Country Status (12)

Country Link
US (1) US3375247A (fr)
AT (2) AT266143B (fr)
BE (1) BE684912A (fr)
BR (1) BR6681735D0 (fr)
CH (2) CH460025A (fr)
DE (1) DE1620140C3 (fr)
DK (1) DK128812B (fr)
ES (1) ES329747A1 (fr)
FR (2) FR1488185A (fr)
GB (1) GB1089814A (fr)
SE (2) SE325030B (fr)
YU (2) YU34524B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569720A5 (fr) * 1972-10-20 1975-11-28 Hoffmann La Roche
US4016267A (en) * 1974-06-19 1977-04-05 Hoffmann-La Roche Inc. Sulfacytosine derivatives
US3923792A (en) * 1974-06-19 1975-12-02 Hoffmann La Roche Sulfacytosine derivatives
AU2586999A (en) 1998-02-03 1999-08-16 University Of Arkansas, The Method for the stimulation of sperm production and gonadal development in animals

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249603A (en) * 1960-08-09 1966-05-03 Hoffmann La Roche Novel pyrimidine sulfanilamides and processes for their preparation

Also Published As

Publication number Publication date
GB1089814A (en) 1967-11-08
DE1620140C3 (de) 1974-01-31
CH460024A (fr) 1968-07-31
DK128812B (da) 1974-07-08
FR5929M (fr) 1968-04-01
YU160278A (en) 1979-07-10
SE325032B (fr) 1970-06-22
BE684912A (fr) 1967-01-16
YU145766A (en) 1979-02-28
DE1620140B2 (de) 1973-06-14
YU34524B (en) 1979-09-10
FR1488185A (fr) 1967-07-07
YU34681B (en) 1979-12-31
SE325030B (fr) 1970-06-22
ES329747A1 (es) 1967-07-16
DE1620140A1 (de) 1970-03-12
AT266148B (de) 1968-11-11
AT266143B (de) 1968-11-11
BR6681735D0 (pt) 1973-10-25
US3375247A (en) 1968-03-26

Similar Documents

Publication Publication Date Title
CH471833A (fr) Procédé de préparation de stéroïdes-oxazolines
CH474494A (fr) Procédé de préparation de nouvelles amines
CH468412A (fr) Procédé de préparation de chlordialcoylthiophosphates
FR89870E (fr) Procédé de préparation de nu-vinyl-amides
FR1503663A (fr) Procédé de préparation de nouvelles pyrimidines
CH435279A (fr) Procédé de préparation de nouvelles quinoléines
FR1515015A (fr) Procédé de préparation de poly-n-oxydes
CH486461A (fr) Procédé de préparation de nouvelles chloroquinoléines
CH460025A (fr) Procédé de préparation de nouvelles cytosines
FR1458925A (fr) Procédé de préparation de nouvelles alpha-aminopénicillines
CH452518A (fr) Procédé de préparation de 17a-acyloxy-11B-hydroxystéroïdes
CH461516A (fr) Procédé de préparation de nouvelles pyridazones
OA02405A (fr) Procédé de préparation de nouvelles chloroquinoleines.
CH508597A (fr) Procédé de préparation de nouvelles imidoylurées
CH489499A (fr) Procédé de préparation de nouvelles chloroquinoléines
FR1510206A (fr) Procédé de préparation de diaza-cyclo-alcanes substitués
FR1455825A (fr) Procédé de préparation de phényl-tétrahydropyridines substituées
OA02022A (fr) Procédé de préparation de nouvelles benzène-sulfonylurées.
CH455779A (fr) Procédé de préparation de nouvelles pyrrolidines
FR1488055A (fr) Procédé de préparation de nouvelles acylcarbodiimides
FR1505675A (fr) Procédé de préparation de 6alpha-fluoro-16-méthylène-stéroïdes
FR1506262A (fr) Procédé de préparation de nouvelles succinimidotétrahydroacénaphtènones
FR1446523A (fr) Procédé de préparation des nouvelles méthyle-2 phényle-3 eta-3 quinazolones-4
FR1489505A (fr) Procédé de préparation de nouvelles alkylénimines
FR1512713A (fr) Procédé de préparation de nouvelles bis-azométhines